The Bill & Melinda Gates Foundation has committed up to $220 million for the next five years to Rockville-based Aeras, a nonprofit dedicated to developing new vaccines for tuberculosis.
The grant extends the Gates Foundation’s longtime backing of Aeras, whose pipeline includes several mid- and early-stage TB vaccine candidates being developed through pharmaceutical and academic partnerships. The $220 million represents about half of what Aeras needs to meet its vaccine development targets through 2016, the nonprofit said in a news release Wednesday.
To read the full, original article click on this link: Bill & Melinda Gates Foundation to give $220 million to Aeras to fight tuberculosis - Washington Business Journal